These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31634191)

  • 41. Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus.
    Hansen SG; Powers CJ; Richards R; Ventura AB; Ford JC; Siess D; Axthelm MK; Nelson JA; Jarvis MA; Picker LJ; Früh K
    Science; 2010 Apr; 328(5974):102-6. PubMed ID: 20360110
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Qualitative T-helper responses to multiple viral antigens correlate with vaccine-induced immunity to simian/human immunodeficiency virus infection.
    Mooij P; Nieuwenhuis IG; Knoop CJ; Doms RW; Bogers WM; Ten Haaft PJ; Niphuis H; Koornstra W; Bieler K; Köstler J; Morein B; Cafaro A; Ensoli B; Wagner R; Heeney JL
    J Virol; 2004 Apr; 78(7):3333-42. PubMed ID: 15016855
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Moving ahead an HIV vaccine: use both arms to beat HIV.
    Walker BD; Ahmed R; Plotkin S
    Nat Med; 2011 Oct; 17(10):1194-5. PubMed ID: 21988996
    [No Abstract]   [Full Text] [Related]  

  • 44. Significant protection against high-dose simian immunodeficiency virus challenge conferred by a new prime-boost vaccine regimen.
    Schell JB; Rose NF; Bahl K; Diller K; Buonocore L; Hunter M; Marx PA; Gambhira R; Tang H; Montefiori DC; Johnson WE; Rose JK
    J Virol; 2011 Jun; 85(12):5764-72. PubMed ID: 21490100
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity.
    Cole KS; Rowles JL; Jagerski BA; Murphey-Corb M; Unangst T; Clements JE; Robinson J; Wyand MS; Desrosiers RC; Montelaro RC
    J Virol; 1997 Jul; 71(7):5069-79. PubMed ID: 9188572
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simian Immunodeficiency Virus Infection Modulates CD94
    Ram DR; Lucar O; Hueber B; Reeves RK
    J Virol; 2019 Aug; 93(16):. PubMed ID: 31167916
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protection by dendritic cells-based HIV synthetic peptide cocktail vaccine: preclinical studies in the SHIV-rhesus model.
    Nehete PN; Nehete BP; Manuri P; Hill L; Palmer JL; Sastry KJ
    Vaccine; 2005 Mar; 23(17-18):2154-9. PubMed ID: 15755586
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A clinically relevant HIV-1 subunit vaccine protects rhesus macaques from in vivo passaged simian-human immunodeficiency virus infection.
    Mooij P; van der Kolk M; Bogers WM; ten Haaft PJ; Van Der Meide P; Almond N; Stott J; Deschamps M; Labbe D; Momin P; Voss G; Von Hoegen P; Bruck C; Heeney JL
    AIDS; 1998 Mar; 12(5):F15-22. PubMed ID: 9543435
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vaccine-based, long-term, stable control of simian/human immunodeficiency virus 89.6PD replication in rhesus macaques.
    Yamamoto H; Kawada M; Tsukamoto T; Takeda A; Igarashi H; Miyazawa M; Naruse T; Yasunami M; Kimura A; Matano T
    J Gen Virol; 2007 Feb; 88(Pt 2):652-659. PubMed ID: 17251584
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Partial protection of SHIV-infected Chinese rhesus macaques against super-infection with heterologous SHIV isolate.
    Li Y; Liu Q; Luo Z; Feng Y; Li Z; Wei Q; Shao Y
    Curr HIV Res; 2012 Dec; 10(8):627-35. PubMed ID: 22954309
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.
    Connor RI; Montefiori DC; Binley JM; Moore JP; Bonhoeffer S; Gettie A; Fenamore EA; Sheridan KE; Ho DD; Dailey PJ; Marx PA
    J Virol; 1998 Sep; 72(9):7501-9. PubMed ID: 9696847
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of CD40L by the ALVAC-Simian Immunodeficiency Virus Vector Abrogates T Cell Responses in Macaques.
    Silva de Castro I; Gordon SN; Liu J; Bissa M; McKinnon K; Trinh HV; Doster MN; Schifanella L; Liyanage NP; Cao J; Cheng O; Foulds K; Roederer M; Koup RA; Shen X; Tomaras GD; Venzon DJ; Forthal DN; Fouts T; Montefiori DC; Tartaglia J; Rao M; Ostrowski M; Franchini G; Vaccari M
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31896599
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
    Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Live-attenuated lentivirus immunization modulates innate immunity and inflammation while protecting rhesus macaques from vaginal simian immunodeficiency virus challenge.
    Genescà M; Ma ZM; Wang Y; Assaf B; Qureshi H; Fritts L; Huang Y; McChesney MB; Miller CJ
    J Virol; 2012 Sep; 86(17):9188-200. PubMed ID: 22696662
    [TBL] [Abstract][Full Text] [Related]  

  • 55. rhesus cytomegalovirus (macacine herpesvirus 3)-associated facial neuritis in simian immunodeficiency virus-infected rhesus macaques (Macaca mulatta).
    Assaf BT; Knight HL; Miller AD
    Vet Pathol; 2015 Jan; 52(1):217-23. PubMed ID: 24686387
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Live attenuated rubella vectors expressing SIV and HIV vaccine antigens replicate and elicit durable immune responses in rhesus macaques.
    Virnik K; Hockenbury M; Ni Y; Beren J; Pavlakis GN; Felber BK; Berkower I
    Retrovirology; 2013 Sep; 10():99. PubMed ID: 24041113
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunization with recombinant macaque major histocompatibility complex class I and II and human immunodeficiency virus gp140 inhibits simian-human immunodeficiency virus infection in macaques.
    Yang GB; Wang Y; Babaahmady K; Schøller J; Rahman D; Bunnik E; Spallek R; Zong CM; Duan JZ; Qin C; Jiang H; Singh M; Vaughan R; Bergmeier LA; Schuitemaker H; Shao Y; Lehner T
    J Gen Virol; 2012 Jul; 93(Pt 7):1506-1518. PubMed ID: 22492918
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunogenicity and efficacy of DNA/MVA HIV vaccines in rhesus macaque models.
    Chea LS; Amara RR
    Expert Rev Vaccines; 2017 Oct; 16(10):973-985. PubMed ID: 28838267
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope.
    Barnett SW; Srivastava IK; Kan E; Zhou F; Goodsell A; Cristillo AD; Ferrai MG; Weiss DE; Letvin NL; Montefiori D; Pal R; Vajdy M
    AIDS; 2008 Jan; 22(3):339-48. PubMed ID: 18195560
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Limited impact of passive non-neutralizing antibody immunization in acute SIV infection on viremia control in rhesus macaques.
    Nakane T; Nomura T; Shi S; Nakamura M; Naruse TK; Kimura A; Matano T; Yamamoto H
    PLoS One; 2013; 8(9):e73453. PubMed ID: 24039947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.